Answers are grounded in this paper and cite their sources.
Factor VIII circulates as a heterodimer composed of heavy (A1A2B domains) and light (A3C1C2 domains) chains, whereas the contiguous A1A2 domains are separate subunits in the active cofactor, factor VIIIa. Whereas the A1 subunit maintains a stable interaction with the A3C1C2 subunit, the A2 subunit is weakly associated in factor VIIIa and its dissociation accounts for the labile activity of the cofactor. In examining the ceruloplasmin-based factor VIII A domain model, potential hydrogen bonding based upon spatial separations of <2.8Å were found between side chains of 14 A2 domain residues and 7 and 9 residues in the A1 and A3 domains, respectively. These residues were individually replaced with Ala, except Tyr residues were replaced with Phe, and proteins stably expressed to examine the contribution of each residue to protein stability. Factor VIII stability at 55 °C and factor VIIIa activity were monitored using factor Xa generation assays. Fourteen of 30 factor VIII mutants showed >2-fold increases in either or both decay rates compared with wild type; whereas, 7 mutants showed >2-fold increased rates in factor VIIIa decay compared with factor VIII decay. These results suggested that multiple residues at the A1-A2 and A2-A3 domain interfaces contribute to stabilizing the protein. Furthermore, these data discriminate residues that stabilize interactions in the procofactor from those in the cofactor, where hydrogen bonding in the latter appears to contribute more significantly to stability. This observation is consistent with an altered conformation involving new inter-subunit interactions involving A2 domain following procofactor activation. Factor VIII circulates as a heterodimer composed of heavy (A1A2B domains) and light (A3C1C2 domains) chains, whereas the contiguous A1A2 domains are separate subunits in the active cofactor, factor VIIIa. Whereas the A1 subunit maintains a stable interaction with the A3C1C2 subunit, the A2 subunit is weakly associated in factor VIIIa and its dissociation accounts for the labile activity of the cofactor. In examining the ceruloplasmin-based factor VIII A domain model, potential hydrogen bonding based upon spatial separations of <2.8Å were found between side chains of 14 A2 domain residues and 7 and 9 residues in the A1 and A3 domains, respectively. These residues were individually replaced with Ala, except Tyr residues were replaced with Phe, and proteins stably expressed to examine the contribution of each residue to protein stability. Factor VIII stability at 55 °C and factor VIIIa activity were monitored using factor Xa generation assays. Fourteen of 30 factor VIII mutants showed >2-fold increases in either or both decay rates compared with wild type; whereas, 7 mutants showed >2-fold increased rates in factor VIIIa decay compared with factor VIII decay. These results suggested that multiple residues at the A1-A2 and A2-A3 domain interfaces contribute to stabilizing the protein. Furthermore, these data discriminate residues that stabilize interactions in the procofactor from those in the cofactor, where hydrogen bonding in the latter appears to contribute more significantly to stability. This observation is consistent with an altered conformation involving new inter-subunit interactions involving A2 domain following procofactor activation. Factor VIII, a plasma protein that participates in the blood coagulation cascade, is decreased or defective in individuals with hemophilia A. Factor VIII circulates as a non-covalent, metal ion-dependent heterodimer consisting of a heavy chain comprised of A1(a1)A2(a2)B 2Lower case a represents short (∼30 residue) segments rich in acidic residues. domains and a light chain comprised of (a3)A3C1C2 domains (see Ref. 1Fay P.J. Blood Rev. 2004; 18: 1-15Crossref PubMed Scopus (161) Google Scholar for review). The factor VIII procofactor is activated by limited proteolysis catalyzed by thrombin or factor Xa to yield the cofactor, factor VIIIa, following cleavages at the a1A2, a2B, and a3A3 junctions. Thus, factor VIIIa is a heterotrimer of subunits designated A1, A2, and A3C1C2. Factor VIIIa functions as a cofactor for the serine protease factor IXa in the membrane-dependent conversion of zymogen factor X to the serine protease, factor Xa (see Ref. 1Fay P.J. Blood Rev. 2004; 18: 1-15Crossref PubMed Scopus (161) Google Scholar for review). The role of the cofactor in the intrinsic factor Xase complex is to increase the catalytic efficiency of this reaction by several orders of magnitude. Factor Xase is self-dampening as a result of instability in the factor VIIIa cofactor due to weak electrostatic interactions between the A2 subunit and the A1/A3C1C2 dimer (2Fay P.J. Haidaris P.J. Smudzin T.M. J. Biol. Chem. 1991; 266: 8957-8962Abstract Full Text PDF PubMed Google Scholar, 3Lollar P. Parker C.G. J. Biol. Chem. 1990; 265: 1688-1692Abstract Full Text PDF PubMed Google Scholar). Limited information is available regarding the association of the A2 subunit in factor VIIIa. Fluorescence energy transfer results (4Nogami K. Wakabayashi H. Schmidt K. Fay P.J. J. Biol. Chem. 2003; 278: 1634-1641Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar) and activity assays following swapping the human A1 domain for the porcine homolog (5Parker E.T. Doering C.B. Lollar P. J. Biol. Chem. 2006; 281: 13922-13930Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar) suggest that interactions of the A2 subunit with the A1 subunit of the A1/A3C1C2 dimer account for the bulk of the binding energy. However, contributions to inter-A2 subunit affinity are also derived from the A3C1C2 subunit. Several factor VIII point mutations have been shown to facilitate A2 dissociation compared with WT 3The abbreviations used are: WT, wild type; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine. factor VIIIa, and include R531H, A284E, A284P, and S289L at the modeled A1-A2 domain interface (6Pipe S.W. Eickhorst A.N. McKinley S.H. Saenko E.L. Kaufman R.J. Blood. 1999; 93: 176-183Crossref PubMed Google Scholar, 7Pipe S.W. Saenko E.L. Eickhorst A.N. Kemball-Cook G. Kaufman R.J. Blood. 2001; 97: 685-691Crossref PubMed Scopus (85) Google Scholar) and N694I, R698L, and R698W at the modeled A2-A3 domain interface (8Hakeos W.H. Miao H. Sirachainan N. Kemball-Cook G. Saenko E.L. Kaufman R.J. Pipe S.W. Thromb. Haemostasis. 2002; 88: 781-787Crossref PubMed Scopus (42) Google Scholar). These molecules demonstrate a characteristic one-stage/two-stage assay discrepancy (9Duncan E.M. Duncan B.M. Tunbridge L.J. Lloyd J.V. Br. J. Haematol. 1994; 87: 846-848Crossref PubMed Scopus (82) Google Scholar, 10Rudzki Z. Duncan E.M. Casey G.J. Neumann M. Favaloro E.J. Lloyd J.V. Br. J. Haematol. 1996; 94: 400-406Crossref PubMed Scopus (79) Google Scholar), reflecting as much as 50% reduced activity in the latter assay as a result of increased A2 dissociation. Examination of the ceruloplasmin-based homology model for the A domains of factor VIII (11Pemberton S. Lindley P. Zaitsev V. Card G. Tuddenham E.G. Kemball-Cook G. Blood. 1997; 89: 2413-2421Crossref PubMed Google Scholar) suggests a relatively large area contributes to the A2-interactive interface with A1 and A3 domains. Consistent with this observation, we identified 30 charged or polar residues including Glu1829 (12Wakabayashi H. Zhou Q. Varfaj F. Fay P.J. J. Thromb. Haemostasis. 2007; 5: 996-1001Crossref PubMed Scopus (3) Google Scholar) buried at the A2-interactive surface that may potentially form inter-domain hydrogen bonds, based upon spatial separations of <2.8 Å, contributing to the overall binding energy (13Pace C.N. Shirley B.A. McNutt M. Gajiwala K. FASEB J. 1996; 10: 75-83Crossref PubMed Scopus (558) Google Scholar, 14Thurlkill R.L. Grimsley G.R. Scholtz J.M. Pace C.N. J. Mol. Biol. 2006; 362: 594-604Crossref PubMed Scopus (57) Google Scholar). To determine a role for these residues in the stability of factor VIIIa, as well as the factor VIII procofactor, we employed a site-directed mutagenesis approach where each of these residues was individually replaced by Ala (Phe for Tyr residues) and the resulting factor VIII variants were stably expressed as B-domainless factor VIII in baby hamster kidney cells. The purified proteins were evaluated for thermostability of the factor VIII procofactor following incubation at 55 °C and the intrinsic stability of factor VIIIa following activation of the procofactor by thrombin. Results from this study identify residues that contribute to protein stability, likely through participation in hydrogen bonding at the inter-subunit interface. Furthermore, a subset of these residues makes differential contributions to stability of the two protein forms consistent with a change in bonding pattern upon procofactor activation. Reagents—Recombinant factor VIII (Kogenate™) was a gift from Dr. Lisa Regan of Bayer Corporation (Berkeley, CA). Phospholipid vesicles containing 20% PC, 40% PE, and 40% PS were prepared using octyl glucoside as described previously (15Mimms L.T. Zampighi G. Nozaki Y. Tanford C. Reynolds J.A. Biochemistry. 1981; 20: 833-840Crossref PubMed Scopus (557) Google Scholar). The reagents α-thrombin, factor IXaβ, factor X, and factor Xa (Enzyme Research Laboratories, South Bend, IN), hirudin and phospholipids (DiaPharma, West Chester, OH), the chromogenic Xa substrate, Pefachrome Xa (Pefa-5523, CH3OCO-d-CHA-Gly-Arg-pNA·AcOH; Centerchem Inc. Norwalk CT), and Phe-Pro-Arg-chloromethyl ketone (PPACK, Calibiochem, La Jolla, CA) were purchased from the indicated vendors. Construction, Expression, and Purification of WT and Variant Factor VIII—Mutants and WT factor VIII forms were constructed as a B-domainless factor VIII, stably expressed in baby hamster kidney cells, and purified as described previously (16Wakabayashi H. Freas J. Zhou Q. Fay P.J. J. Biol. Chem. 2004; 279: 12677-12684Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar). Protein yields for the variants ranged from >10 to ∼100 μg from two 750-cm2 culture flasks, with purity from ∼85 to >95% as judged by SDS-PAGE. Factor VIII concentration was measured by enzyme-linked immunosorbent assay and factor VIII activity was determined by a one-stage clotting assay and a two-stage chromogenic factor Xa generation assay (see below). Enzyme-linked Immunosorbent Assay—A sandwich enzyme-linked immunosorbent assay was performed to measure the concentration of factor VIII proteins as previously described (17Wakabayashi H. Su Y.C. Ahmad S.S. Walsh P.N. Fay P.J. Biochemistry. 2005; 44: 10298-10304Crossref PubMed Scopus (19) Google Scholar) using purified commercial recombinant factor VIII (Kogenate, Bayer Corporation) as a standard. One-stage Clotting Assay—One-stage clotting assays were performed using substrate plasma chemically depleted of factor VIII (18Over J. Scand. J. Haematol. Suppl. 1984; 41: 13-24PubMed Google Scholar) and assayed using a Diagnostica Stago clotting instrument. Plasma was incubated with activated partial thromboplastin time reagent (General Diagnostics) for 6 min at 37 °C at which time a dilution of factor VIII was added to the cuvette. After 1 min the mixture was recalcified and the time to clot formation determined and compared with a pooled normal plasma standard. Two-stage Chromogenic Factor Xa Generation Assay—The rate of conversion of factor X to factor Xa was monitored in a purified system (19Lollar P. Fay P.J. Fass D.N. Methods Enzymol. 1993; 222: 128-143Crossref PubMed Scopus (94) Google Scholar) according to previously described H. M. Fay P.J. Biochemistry. 2001; PubMed Scopus Google Scholar, H. Schmidt Fay P.J. Biochemistry. 2002; 41: PubMed Scopus Google Scholar). factor VIII in containing and vesicles was activated with for 1 The reaction was by hirudin and the factor VIIIa was with factor IXa for 1 Factor X was added to the reaction and 1 the reaction was by of Factor Xa was determined following reaction with the chromogenic substrate Pefachrome Xa were at Factor VIII at and factor VIII variants in A were incubated at 55 were at the indicated and activity was determined using a two-stage chromogenic factor Xa generation assay as described Factor VIIIa assays performed in the of factor IXa and WT and factor VIII variants in A were activated by thrombin for 1 was with hirudin and incubated at were at the indicated and factor VIIIa activity was determined using the factor Xa generation assay following of the with factor factor VIIIa decay performed in the of factor the time for thrombin activation was to to factor VIIIa decay. Factor IXa was added to the reaction time to of the with factor VIIIa activity as a of time were to a decay by using the where A is cofactor activity factor is the is the rate and is the time in of reaction of factor VIII at factor VIII decay or following thrombin activation factor VIIIa decay was performed by of was performed by the The factor VIII A domain modeled was by the to hydrogen at a of between hydrogen and N. 1997; 18: PubMed Scopus Google Scholar). for Factor VIII interactions involving the A2 domain in factor VIII a for the of cofactor The factor VIII homology model (11Pemberton S. Lindley P. Zaitsev V. Card G. Tuddenham E.G. Kemball-Cook G. Blood. 1997; 89: 2413-2421Crossref PubMed Google Scholar) the potential for hydrogen residues in the A2 domain with those in the A1 or A3 domains. a for a spatial of <2.8 between hydrogen and C. G. S. J. Chem. 1984; Scopus Google Scholar) we identified 30 residues in which a side chain may in hydrogen bonding with an from a A domain In of the residues side chain were with either or hydrogen whereas the interactions between side residues in the factor VIII A domains were individually to Ala, with the that Tyr residues were replaced with Phe, and the point mutations were stably expressed as B-domainless factor residues of hydrogen residue hydrogen hydrogen in a new Factor VIII activity was measured for the purified proteins using a one-stage clotting assay and a factor Xa generation assay Results from the one-stage assay indicated that 9 of the 30 point mutants showed activity to WT factor of these variants a one-stage/two-stage assay discrepancy with mutants and in the two-stage The reduced activity for in several residues were consistent with a contribution of those side chains to the stability of factor VIII factor VIIIa. of Factor VIII the stability of the WT procofactor and a at 55 °C was employed based upon factor VIII results described in an study C. Fay P.J. Biochemistry. 2005; 44: PubMed Scopus Google Scholar). these factor VIII was incubated for the indicated at the which the reaction mixture was to and factor VIII with thrombin and assayed for cofactor activity using a factor Xa generation of a factor VIII activity to the as judged cofactor was determined as described and results for variants the and the to compared with Results for the variants are as and the results from factor VIII thermostability assays for the 30 these activity data well to a decay with in Whereas a of mutations were with to the in rates of several residues including and A2 domain residues and showed increased rates in factor VIII decay an role for these residues in factor VIII stability. Furthermore, the and variants showed significantly reduced activity both activity and stability were by the point the of and with Ala reduced rates for factor VIII decay at the This increase in protein stability following is consistent with these acidic side chains inter-domain VIII and VIIIa decay rates and activity rates in performed in the of factor performed in the of factor in are to wild factor Xa factor performed in the of factor performed in the of factor in are to wild factor Xa factor in a new Factor VIIIa VIIIa activity is labile due to A2 subunit dissociation (2Fay P.J. Haidaris P.J. Smudzin T.M. J. Biol. Chem. 1991; 266: 8957-8962Abstract Full Text PDF PubMed Google Scholar, 3Lollar P. Parker C.G. J. Biol. Chem. 1990; 265: 1688-1692Abstract Full Text PDF PubMed Google Scholar). Results from showed that of factor IXa and vesicles with factor VIIIa to form the Xase complex reduced the of the cofactor P. G.J. Fass D.N. Blood. 1984; PubMed Google Scholar, Fay P.J. J. Biol. Chem. Full Text PDF PubMed Google Scholar) by stabilizing the A2 subunit factor Xase P.J. Regan Kaufman R.J. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar). used this approach to examine the decay rate for an factor VIIIa (12Wakabayashi H. Zhou Q. Varfaj F. Fay P.J. J. Thromb. Haemostasis. 2007; 5: 996-1001Crossref PubMed Scopus (3) Google Scholar) the activity decay of this factor VIIIa in the of factor IXa and was to This approach was employed to rates for factor VIIIa decay for the of variants described in the Factor VIII was incubated with a of factor IXa and activated with and factor Xase activity was measured a time at of decay of factor Xase activity was to A2 subunit dissociation and data were using a decay. the for the affinity of A2 subunit factor VIIIa (12Wakabayashi H. Zhou Q. Varfaj F. Fay P.J. J. Thromb. Haemostasis. 2007; 5: 996-1001Crossref PubMed Scopus (3) Google Scholar) and the factor VIIIa concentration used in the the of of A2 subunit is of a for this Results are in that data for the variants as well as those variants a to the for the variants are as 7 variants increases in rates of factor VIIIa decay compared with WT and These mutations for the are from Ref. H. Zhou Q. Varfaj F. Fay P.J. J. Thromb. Haemostasis. 2007; 5: 996-1001Crossref PubMed Scopus (3) Google and Factor VIII activity for these variants as measured by a two-stage assay were significantly those determined by the one-stage assay consistent with the mutations to rates of A2 subunit dissociation. Furthermore, several of these mutations including and showed overall activity in the one-stage is the case for factor VIII mutants this assay activity determined from the one-stage assay was also reduced (6Pipe S.W. Eickhorst A.N. McKinley S.H. Saenko E.L. Kaufman R.J. Blood. 1999; 93: 176-183Crossref PubMed Google Scholar, 7Pipe S.W. Saenko E.L. Eickhorst A.N. Kemball-Cook G. Kaufman R.J. Blood. 2001; 97: 685-691Crossref PubMed Scopus (85) Google Scholar, W.H. Miao H. Sirachainan N. Kemball-Cook G. Saenko E.L. Kaufman R.J. Pipe S.W. Thromb. Haemostasis. 2002; 88: 781-787Crossref PubMed Scopus (42) Google Scholar), reflecting of A2 dissociation rates factor VIII variants and that WT factor VIII also stability of factor VIIIa as judged by in the rates of cofactor decay following activation by thrombin. Results with the were more and showed an reduced rate of cofactor decay to WT factor VIIIa, of its activity the concentration of factor IXa used in the factor VIII those mutations rates for decay to wild were also evaluated in the of added factor IXa to that the decay from a in interactions of the with factor IXa and of the WT factor VIII forms showed an increase in the factor VIIIa decay rate in the of factor IXa compared with its and this result was consistent with partial of the cofactor these P.J. Regan Kaufman R.J. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar). The variants and significantly decay rates to the WT that the decay result from a in factor IXa The of factor VIIIa stability to a more that for procofactor stability 7 mutants showed >2-fold rates of factor VIIIa decay compared with factor VIII decay. the two variants and showed significantly increased factor VIII decay rates compared with factor VIIIa decay This latter observation was consistent with the mutations conformation at the inter-domain interface in the these results identify contributions of multiple residues to inter-A2 subunit interactions in the procofactor and cofactor forms of factor VIII with residues contributions to protein stability. that the association of A2 subunit in factor VIIIa is by electrostatic interactions P.J. Smudzin T.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar) the for of hydrogen bonding interactions at the A2 domain interface. Examination of the ceruloplasmin-based homology model of the A domains of factor VIII identified 30 residues that contribute hydrogen bonding to stabilize interactions of the A2 domain in the and cofactor forms of the protein. mutations to or in of the variants increases in rates of following reaction of the procofactor to resulting from decay of factor VIIIa. of factor VIIIa activity of factor VIII stability with 7 mutations the of which showed a characteristic one-stage/two-stage assay discrepancy consistent with dissociation of the A2 subunit. is also that mutations identified at 9 residues of the 30 residues with or with or with with and are in the A data G. Tuddenham E.G. PubMed Scopus Google Scholar) as of the results that at 7 of these residues increases in procofactor cofactor decay rates consistent with of the protein the residues to the modeled factor VIII A domains suggested contributing to interaction of the A2 domain with the A1 and A3 domains. the modeled factor VIII with a A2 domain the A1 and A3 domains. are indicated and are A of is used to the of at a residue either factor VIII to or factor VIIIa to decay designated and that and showed of stability a role for side chains of these residues in an The is in which showed increases in both factor VIII and factor VIIIa decay the of of the residues in which represents an A2 interface with the A1 increases in the rates of factor decay. of these and showed increases in factor VIII decay and to increases in factor VIIIa a contribution to inter-domain affinity is derived from this interface between A1 and Furthermore, this observation is consistent with a role for the A1 subunit in A2 subunit following procofactor activation (4Nogami K. Wakabayashi H. Schmidt K. Fay P.J. J. Biol. Chem. 2003; 278: 1634-1641Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar, E.T. Doering C.B. Lollar P. J. Biol. Chem. 2006; 281: 13922-13930Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar). which interaction of the A2 and A3 domains, of which protein stability following However, several residues of were for stability of both procofactor and cofactor as judged by and increases in decay rates following with a of residues in this to a contribution to cofactor stability compared with that of the where mutations the factor VIII stability a of Glu1829 (see and However, those residues the factor VIIIa stability in the Glu1829 residues and and intrinsic to the interaction of the A2 domain factor VIII as well as of the A2 subunit following at the A1-A2 by thrombin. However, residues and each contributions to A2 subunit in factor VIIIa contributions to the stability of factor The of this of mutations suggest a change in the overall of bonding interactions upon of the contiguous A1-A2 domains activation of the The activation of factor VIII to factor VIIIa is by in protein The A2 domain is a point for change to altered as this domain the protease domain of factor IXa Schmidt A. K. M. Fay P.J. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). in of a factor IXa active were using an A2 subunit in the and of the A1 subunit compared with factor VIII heavy chain A1-A2 domains) P.J. M. Wakabayashi H. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). upon the we that associated with activation are derived in large from in bonding of the A2 subunit factor VIIIa that residues including and in this (12Wakabayashi H. Zhou Q. Varfaj F. Fay P.J. J. Thromb. Haemostasis. 2007; 5: 996-1001Crossref PubMed Scopus (3) Google Scholar) showed that the activity and relatively decay of factor VIIIa the from an in the affinity of A2 subunit for the A1/A3C1C2 subunit this in the A3 to the ceruloplasmin-based homology model, the side chain of Glu1829 is to form hydrogen to both hydrogen and of in the A2 subunit (see the residues for the increases to factor VIII side chains from 6 are to in and are to form a bonding The two and to with side chain from and respectively. mutations at these latter residues showed protein stability these may suggest bonding interactions at differential for reduced stability due to at and Whereas the of at the residues were for the either or we that at two A1 domain acidic and in stability in both and active cofactor The activity of was reduced compared with WT, whereas the activity for the were from the WT and suggest the latter a The for the of the variants is suggests may result from the at the interface an increase in stability these residue side chains are information of factor VIII is of the ceruloplasmin-based homology model for factor VIII in this mutagenesis and study a in that at of the residues to in hydrogen bonding protein stability. the of this a of the human factor VIII procofactor was J. Blood. PubMed Scopus Google Scholar). Whereas this of of hydrogen bonding interactions the of the study indicated that the A domains of factor VIII those of with a of of the in may yield new residues to for contributions to the interactions involving A2 in VIII and VIIIa. However, the results in the study information to in of factor VIII Furthermore, this approach to bonding interactions yield that conversion of the procofactor to cofactor and may identify variants that have for Lisa M. Regan for the of recombinant human factor VIII and Zhou for with
No takes yet. Share an insight, caveat, or question.
Wakabayashi et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: